Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. - Wikidata - wikimedia - TriplyDB

Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

http://www.wikidata.org/entity/Q35602671

about

The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.Regulation of Vascular and Renal Function by Metabolite Receptors LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia.Lithium in the Kidney: Friend and Foe?Functional and therapeutic importance of purinergic signaling in polycystic kidney disease.Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925.Purinergic Signalling: Therapeutic Developments.Acute In Vivo Analysis of ATP Release in Rat Kidneys in Response to Changes of Renal Perfusion Pressure.CD39-adenosinergic axis in renal pathophysiology and therapeutics.Vitamin supplementation.Channels and channelopathies.

P2860

Q26768170-13028138-4F5E-4D84-94E3-F2E3447D9174 Q30249421-14359B05-B0E7-40DC-AC9C-D51A6E264BEB Q36752430-25EC423D-2AB3-437A-8F49-72AFA28ECE32 Q36828020-A81A1278-1D18-47B3-AFEB-1A3B65E7B033 Q38636263-D7DE1118-5DBB-46DD-BC14-B0E586ABC8F5 Q38961131-8CBC9285-CD4D-48B1-AFC8-5B699BB6B165 Q41815006-D4D7F6C9-2335-4ADF-B1A0-A396F07DD7EF Q42367885-AE7858A6-6ED2-4C6A-8AE8-A1599130577B Q42373746-8AFD6AE1-4763-4C4F-B8BC-1B8395009789 Q47655859-E6D09868-EE93-432A-BF02-BB4B5CEFD61E Q52842384-AAD8006A-D75D-4899-B4B9-78DF8AE2A2F7 Q52848059-B2033BC7-DA12-4F40-A121-88AED85EB942

P2860

Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.

http://www.wikidata.org/entity/Q35602671

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@ast

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@en

type

label

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@ast

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@en

prefLabel

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@ast

Targeting renal purinergic sig ...... ephrogenic diabetes insipidus.

@en

P1433

Q35602671-C1B5DD24-EBCB-48A0-AB0F-64A071E32DF7

P1476

Q35602671-36FA40B3-3886-4255-8974-C7E4062DDACB

P2093

Q35602671-43427B4D-22AB-4FA9-B757-E8DFA977791B

Q35602671-52C3E9E3-83DB-496F-BBCF-420C25152833

Q35602671-711D4A36-F5DF-424D-8DF8-B7878D234ED1

Q35602671-847D0227-E817-420F-B8AD-D57F20EFB6F7

Q35602671-A2829B0A-3180-4D83-8355-626343414AC8

Q35602671-ADBEB622-A0CB-4CB3-B4BD-ABEE948BC0D6

P2860

Q35602671-00009070-882C-4A13-9F29-A742CC183185

Q35602671-05AE4DB2-144B-4B40-AD00-7A73BDB199D7

Q35602671-07785E60-82C9-44EE-AD3A-200CAD685E8A

Q35602671-09852395-00F2-432B-954A-8CAA4AB921BE

Q35602671-09D0731F-6786-4B6F-9897-779BF45AD397

Q35602671-09D4951C-F177-4D4F-A533-D3CE3FAB58A4

Q35602671-0B11BCFC-755C-4D86-B573-EF28DDAD9521

Q35602671-0D557910-75A9-4FB4-BD76-9B3DC0B67597

Q35602671-108431B6-BCBF-4EE5-AF01-3415CCF116B3

Q35602671-10EF75D3-16DA-4FA6-83CD-F9DDCA0DE71A

P304

Q35602671-25D491D5-4B5E-45CB-8FB3-A97182A04FAE

P31

Q35602671-51AB7EB9-2556-4DE2-BB26-50118A57151A

P356

Q35602671-23E351C8-7CFE-4E52-88E9-AFA7DAED4820

P433

Q35602671-92D5E026-37FE-42C2-880E-67709A75C061

P478

Q35602671-D4258963-4585-42F2-AD2E-F954DDA8221C

P50

Q35602671-A5CB7C11-034E-4A8C-BFC2-8A7378A84513

Q35602671-AEC6AAAB-17B8-4BB2-8D5F-F332BD660765

P577

Q35602671-CF3C65CE-8001-4C97-B1D5-822CE31421A3

P698

Q35602671-6BBF0916-32DB-46BC-A668-F09D185F9FDE

P932

Q35602671-15D0E935-DDD1-430A-98AE-0603145410C5

P356

P1433

Acta Physiologica

P1476

Targeting renal purinergic sig ...... nephrogenic diabetes insipidus

@en

P2093

C M Ecelbarger

http://www.w3.org/2001/XMLSchema#string

D E Kohan

http://www.w3.org/2001/XMLSchema#string

J Peti-Peterdi

http://www.w3.org/2001/XMLSchema#string

N G Carlson

http://www.w3.org/2001/XMLSchema#string

R D Nelson

http://www.w3.org/2001/XMLSchema#string

Y Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity

Molecular regulation of NKCC2 in the thick ascending limb

Structure of the human P2Y12 receptor in complex with an antithrombotic drug

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs

Lithium salts in the treatment of psychotic excitement

Intrarenal purinergic signaling in the control of renal tubular transport

P2 receptors activated by uracil nucleotides--an update

Chronic interstitial nephropathy in patients on long-term lithium treatment

Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate

P304

176-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APHA.12507

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P50

Christa E Müller

Bellamkonda Kishore

P577

2015-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25877068

http://www.w3.org/2001/XMLSchema#string

P932

4430398

http://www.w3.org/2001/XMLSchema#string